000 | 01222 a2200361 4500 | ||
---|---|---|---|
005 | 20250514022615.0 | ||
264 | 0 | _c20020306 | |
008 | 200203s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood.v99.3.759 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTallman, Martin S | |
245 | 0 | 0 |
_aAcute promyelocytic leukemia: evolving therapeutic strategies. _h[electronic resource] |
260 |
_bBlood _cFeb 2002 |
||
300 |
_a759-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aArsenic Trioxide |
650 | 0 | 4 |
_aArsenicals _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xdrug therapy |
650 | 0 | 4 |
_aOxides _xtherapeutic use |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aTretinoin _xtherapeutic use |
700 | 1 | _aNabhan, Chadi | |
700 | 1 | _aFeusner, James H | |
700 | 1 | _aRowe, Jacob M | |
773 | 0 |
_tBlood _gvol. 99 _gno. 3 _gp. 759-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood.v99.3.759 _zAvailable from publisher's website |
999 |
_c11717654 _d11717654 |